June 27, 2024
The U.S. Supreme Court shot down the validity of nonconsensual third-party releases in an opinion issued Thursday in the case of bankrupt drugmaker Purdue Pharma LP, potentially exposing the Sackler family members who own the company to personal liability for the company's role in the opioid crisis.
June 01, 2024
As the calendar flips over to June, the U.S. Supreme Court still has heaps of cases to decide on issues ranging from trademark registration rules to judicial deference and presidential immunity. Here, Law360 looks at 10 of the most important topics the court has yet to decide.
May 16, 2024
The U.S. Supreme Court may have declined to hear a challenge to non-debtor litigation stays in mass tort bankruptcies this week in the Chapter 11 case of Georgia-Pacific's asbestos spinoff, but it is still slated to hand down decisions with the potential for wide-reaching impacts to mass torts and beyond this term.
January 08, 2024
When 2024 began, the U.S. Supreme Court's docket — spanning abortion, guns, social media, the modern regulatory system and more — already seemed certain to shake up the nation's cultural and economic landscapes. But now there's also a showdown involving Donald Trump and America's constitutional bedrock, auguring a truly tectonic term.
January 01, 2024
A wide variety of cases are likely to keep retail industry attorneys busy in 2024, including high-profile antitrust actions against Amazon and Google, a growing number of greenwashing disputes, and skirmishes between major retailers and their increasingly unionized workforces.
December 04, 2023
As Purdue Pharma LP and its creditors pushed the U.S. Supreme Court on Monday to bless liability releases granted to members of the Sackler family who own it, a skeptical Justice Ketanji Brown Jackson said it was the owners themselves who created the necessity in the first place by withdrawing billions of dollars from the business before its bankruptcy.
December 04, 2023
U.S. Supreme Court justices on Monday challenged a bankruptcy watchdog's position that members of the Sackler family shouldn't get a liability shield in Purdue's Chapter 11 plan, focusing discussion on why such immunity might never be appropriate in the most foundational bankruptcy dispute to make it to the high court in several years.
December 01, 2023
The U.S. Supreme Court returns Monday for the last argument session of the calendar year to consider whether bankruptcy courts have the authority to sign off on third-party liability releases in Chapter 11 plans, whether Congress can tax unrealized foreign gains, and which standard should be used to determine the viability of employment discrimination claims.
December 01, 2023
Purdue Pharma's oral arguments before the U.S. Supreme Court on Monday are likely to cover several exalted ideas, including the constitutional limits of America's bankruptcy code and the moral implications of letting billionaires off the hook for their company's role in the opioid epidemic. But some experts say the case threatens a humbler factor at the very heart of bankruptcy practice itself: pragmatism.
November 06, 2023
The U.S. Supreme Court will allow creditors of Purdue Pharma LP to make their own oral arguments in a case that asks whether the U.S. Bankruptcy Code authorizes as part of a Chapter 11 plan the release of third-party claims against members of the Sackler family.